GENDER SPECIFIC CHANGES IN MOUSE BLOOD ESTRERASE PROFILE AT THE ACUTE INTOXICATION BY 2-(О-CRESYL)-4Н-1,3,2-BENZODIOXAPHOSPHORIN-2-OXIDE
https://doi.org/10.36946/0869-7922-2017-1-47-51
Abstract
About the Authors
D. S. ProkofievaRussian Federation
188663, Saint Petersburg
V. I. Shmurak
Russian Federation
188663, Saint Petersburg
E. A. Bodryakova
Russian Federation
188663, Saint Petersburg
N. G. Voitenko
Russian Federation
188663, Saint Petersburg
References
1. Li B., Sedlacek M., Manoharan I., Boopathy R., Duysen E.G., Masson P., Lockridge O. Butyrylcholinesterase, paraoxonase, and albumin esterase, but not carboxylesterase, are present in human plasma. Biochem. Pharmacol. 2005; 70(11):1673-84.
2. Bahar F.G., Ohura K., Ogihara T., Imai T. Species Difference of Esterase Expression and Hydrolase Activity in Plasma. J. Pharm. Sci. 2012; 101(10):3979-88.
3. Berry l.M., Wollenberg l., Zhao Z. Esterase activities in the blood, liver and intestine of several preclinical species and humans. Drug Metab. Lett. 2009; 3(2):70-77.
4. Bełtowski J., Wójcicka G., Marciniak A. Species- and substrate-specific stimulation of human plasma paraoxonase 1 (PON1) activity by high chloride concentration. Acta Biochim. Pol. 2002; 49(4):927-936.
5. Clement J G., Erhardt N. Serum carboxylesterase activity in various strains of rats: sensitivity to inhibition by CBDP (2-/o-cresyl/4H:1:3:2-benzodioxaphosphorin2-oxide). Arch. Toxicol. 1990; 64(5): 414– 416.
6. Duysen E.G., Koentgen F., Williams G.R., timperley c.m., schopfer l.m., cerasoli d.m., lockridge o. Production of ES1 plasma carboxylesterase knockout mice for toxicity studies. Chem. Res. Toxicol. 2011; 24(11): 1891-1898.
7. Garrett T.l., Rapp C.M., Grubbs R.D., Schlager J.J., lucot J.B. A murine model for sarin exposure using the carboxylesterase inhibitor CBDP. Neurotoxicology. 2010; 31(5):502-8.
8. Maxwell D.M., Brecht K.M., Lenz D.E., O’Neill B.L. Effect of carboxylesterase inhibition on carbamate protection against soman toxicity. J. Pharmacol. Exp. Ther. 1988; 246(3):986-991.
9. Clement J.G. Importance of aliesterase as a detoxification mechanism for soman (Pinacolyl methylphosphonofluoridate) in mice. Biochem. Pharmacol. 1984; 33(23):3807-3811.
10. Jokanović M. Role of carboxylesterase in soman, sarin and tabun poisoning in rats. Pharmacol. Toxicol. 1989;65(3):181-184.
11. Yang Z.P.,DettbarnW-D. Prevention of Tolerance to the Organophosphorus Anticholinesterase Paraoxon with Carboxylesterase Inhibitors. Biochemical. Pharmacology. 1998; 55(9): 1419–1426.
12. Tuovinen K.,Kaliste-Korhonen E.,Hänninen O. Gender differences in activities of mouse esterase and sensitivities to DFP and sarin toxicity. Gen. Pharmacol. 1997; 29(3): 333-5.
13. Wehner J.M., Murphy-Erdosh C., Smolen A., Smolen T.N. Genetic variation in paraoxonase activity and sensitivity to diisopropylphosphofluoridate in inbred mice. Pharmacol. Biochem. Behav. 1987;28(2):317-20.
14. Djeridane A., Yousfi M., Nadjemi B., Maamri S., Djireb F., Stocker P. Phenolic extracts from various Algerian plants as strong inhibitors of porcine liver carboxylesterase. J. Enzyme Inhib. Med. Chem. 2006; 21(6):719- 26.
15. Nomeir A.A., Abou-Sonia M.B. Studies on the metabolism of neurotoxic tri-o-cresyl phosphate. Toxicology. 1986; 38: 1-13.
Review
For citations:
Prokofieva D.S., Shmurak V.I., Bodryakova E.A., Voitenko N.G. GENDER SPECIFIC CHANGES IN MOUSE BLOOD ESTRERASE PROFILE AT THE ACUTE INTOXICATION BY 2-(О-CRESYL)-4Н-1,3,2-BENZODIOXAPHOSPHORIN-2-OXIDE. Toxicological Review. 2017;(1):47-51. (In Russ.) https://doi.org/10.36946/0869-7922-2017-1-47-51